was read the article
array:25 [ "pii" => "S0001731023000716" "issn" => "00017310" "doi" => "10.1016/j.ad.2022.10.042" "estado" => "S300" "fechaPublicacion" => "2023-03-01" "aid" => "3372" "copyright" => "AEDV" "copyrightAnyo" => "2022" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2023;114:T247-T252" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:19 [ "pii" => "S0001731022007633" "issn" => "00017310" "doi" => "10.1016/j.ad.2021.05.032" "estado" => "S300" "fechaPublicacion" => "2023-03-01" "aid" => "3177" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2023;114:253-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">FORO DE RESIDENTES</span>" "titulo" => "FR – Neoadyuvancia en melanoma" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "253" "paginaFinal" => "254" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "RF – Neoadjuvant Therapy in Melanoma" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Arrieta, M. Blanco de Tord, A. Boada" "autores" => array:3 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Arrieta" ] 1 => array:2 [ "nombre" => "M." "apellidos" => "Blanco de Tord" ] 2 => array:2 [ "nombre" => "A." "apellidos" => "Boada" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022007633?idApp=UINPBA000044" "url" => "/00017310/0000011400000003/v1_202303051528/S0001731022007633/v1_202303051528/es/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S0001731022008948" "issn" => "00017310" "doi" => "10.1016/j.ad.2022.10.034" "estado" => "S300" "fechaPublicacion" => "2023-03-01" "aid" => "3262" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2023;114:247-52" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Dermatoscopia práctica</span>" "titulo" => "¿Es la estimación del tiempo de duplicación tumoral posible y útil en el cáncer de piel?" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "247" "paginaFinal" => "252" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Tumor Doubling Time in Skin Cancer: Can It Be Estimated and Is it Useful?" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2262 "Ancho" => 2007 "Tamanyo" => 709471 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">(1A) Carcinoma epidermoide de cuero cabelludo con un diámetro de 27<span class="elsevierStyleHsp" style=""></span>mm en el tiempo 1 (T1) y un diámetro de 53<span class="elsevierStyleHsp" style=""></span>mm a los 84 días (T2) (1B). (1C) Carcinoma epidermoide de cuero cabelludo con un diámetro de 20<span class="elsevierStyleHsp" style=""></span>mm en el tiempo 1 (T1) y un diámetro de 28<span class="elsevierStyleHsp" style=""></span>mm (1D) a los 133 días, tiempo 2 (T2).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Tejera-Vaquerizo, J. Cañueto, E. Nagore" "autores" => array:3 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Tejera-Vaquerizo" ] 1 => array:2 [ "nombre" => "J." "apellidos" => "Cañueto" ] 2 => array:2 [ "nombre" => "E." "apellidos" => "Nagore" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022008948?idApp=UINPBA000044" "url" => "/00017310/0000011400000003/v1_202303051528/S0001731022008948/v1_202303051528/es/main.assets" ] "asociados" => array:1 [ 0 => array:19 [ "pii" => "S0001731022008948" "issn" => "00017310" "doi" => "10.1016/j.ad.2022.10.034" "estado" => "S300" "fechaPublicacion" => "2023-03-01" "aid" => "3262" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2023;114:247-52" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Dermatoscopia práctica</span>" "titulo" => "¿Es la estimación del tiempo de duplicación tumoral posible y útil en el cáncer de piel?" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "247" "paginaFinal" => "252" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Tumor Doubling Time in Skin Cancer: Can It Be Estimated and Is it Useful?" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2262 "Ancho" => 2007 "Tamanyo" => 709471 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">(1A) Carcinoma epidermoide de cuero cabelludo con un diámetro de 27<span class="elsevierStyleHsp" style=""></span>mm en el tiempo 1 (T1) y un diámetro de 53<span class="elsevierStyleHsp" style=""></span>mm a los 84 días (T2) (1B). (1C) Carcinoma epidermoide de cuero cabelludo con un diámetro de 20<span class="elsevierStyleHsp" style=""></span>mm en el tiempo 1 (T1) y un diámetro de 28<span class="elsevierStyleHsp" style=""></span>mm (1D) a los 133 días, tiempo 2 (T2).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Tejera-Vaquerizo, J. Cañueto, E. Nagore" "autores" => array:3 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Tejera-Vaquerizo" ] 1 => array:2 [ "nombre" => "J." "apellidos" => "Cañueto" ] 2 => array:2 [ "nombre" => "E." "apellidos" => "Nagore" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022008948?idApp=UINPBA000044" "url" => "/00017310/0000011400000003/v1_202303051528/S0001731022008948/v1_202303051528/es/main.assets" ] ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Practical Dermatology</span>" "titulo" => " Tumor Doubling Time in Skin Cancer: Can It Be Estimated and Is It Useful?" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "T247" "paginaFinal" => "T252" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "A. Tejera-Vaquerizo, J. Cañueto, E. Nagore" "autores" => array:3 [ 0 => array:4 [ "nombre" => "A." "apellidos" => "Tejera-Vaquerizo" "email" => array:1 [ 0 => "antoniotejera@aedv.es" ] "referencia" => array:4 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0020" ] 3 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "J." "apellidos" => "Cañueto" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0020" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0015" ] ] ] 2 => array:3 [ "nombre" => "E." "apellidos" => "Nagore" "referencia" => array:4 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0020" ] 3 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0015" ] ] ] ] "afiliaciones" => array:4 [ 0 => array:3 [ "entidad" => "Unidad de Oncología Cutánea, Hospital San Juan de Dios, Córdoba, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Instituto Dermatológico GlobalDerm, Palma del Río (Córdoba), Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Servicio de Dermatología, Instituto Valenciano de Oncología, Valencia, Spain" "etiqueta" => "c" "identificador" => "aff0020" ] 3 => array:3 [ "entidad" => "Servicio de Dermatología, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain" "etiqueta" => "d" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "¿Es la estimación del tiempo de duplicación tumoral posible y útil en el cáncer de piel?" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2263 "Ancho" => 2009 "Tamanyo" => 386787 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Squamous cell carcinoma on the scalp with a diameter of 27<span class="elsevierStyleHsp" style=""></span>mm at time 1 (<span class="elsevierStyleItalic">T</span><span class="elsevierStyleInf">1</span>) (A) and 53<span class="elsevierStyleHsp" style=""></span>mm at <span class="elsevierStyleItalic">T</span><span class="elsevierStyleInf">2</span>, 84 days later (B). Squamous cell carcinoma on the scalp with a diameter of 20<span class="elsevierStyleHsp" style=""></span>mm at <span class="elsevierStyleItalic">T</span><span class="elsevierStyleInf">1</span> (C) and 28<span class="elsevierStyleHsp" style=""></span>mm at 133 days (<span class="elsevierStyleItalic">T</span><span class="elsevierStyleInf">2</span>) (D).</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Cancer is characterized by the uncontrolled growth of transformed cells. It is assumed that a tumor begins as a single transformed cell that divides, or doubles, repeatedly to form 2 and then 4 cells, and so on. Even accounting for the inevitable cell loss that occurs due to phenomena such as apoptosis and tumor necrosis resulting from poor vascularization, it has been estimated that after 40 doublings, a tumor can weigh as much as 1<span class="elsevierStyleHsp" style=""></span>kg. Any subsequent doubling is potentially lethal.<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">1</span></a> Researchers have studied tumor growth for some 80 years in an attempt to better understand the kinetics involved and improve the management of cancer. Most studies have assumed that tumor growth is exponential,<a class="elsevierStyleCrossRefs" href="#bib0145"><span class="elsevierStyleSup">1,2</span></a> but other models have been proposed.<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">3</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Studies analyzing tumor growth have largely analyzed internal tumors, generally by measuring the size of metastases using radiologic images, with the limitations that this entails.<a class="elsevierStyleCrossRefs" href="#bib0160"><span class="elsevierStyleSup">4–6</span></a> In this article, we examine the main evidence on skin tumor kinetics and review the concepts of tumor growth rate and tumor doubling time. We also propose a new method for ascertaining skin tumor doubling time.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Skin Tumor Growth Rate</span><p id="par0015" class="elsevierStylePara elsevierViewall">Because most patients or those close to them tend to remember when they first noticed a skin lesion and more or less recall its appearance, skin tumors, unlike internal tumors, offer the opportunity to assess growth kinetics. According to the National Comprehensive Cancer Network (NCCN) clinical practice guidelines on cutaneous squamous cell carcinoma (cSCC), rapid growth is a potential indicator of a high-risk tumor.<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">7</span></a> The first obvious question, however, is what exactly is meant by rapid growth, as the NCCN does not specify any cutoff values or methods for measuring the growth of cSCCs. The situation is similar for other tumors.</p><p id="par0020" class="elsevierStylePara elsevierViewall">To our knowledge, the first study to analyze tumor growth rate was a study published by Teloh in 1953 on basal cell carcinoma (BCC)<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">8</span></a> in which the author defined rate of growth as follows:<elsevierMultimedia ident="eq0005"></elsevierMultimedia></p><p id="par0025" class="elsevierStylePara elsevierViewall">Size was defined as diameter. Teloh showed that higher rates of growth (>0.7<span class="elsevierStyleHsp" style=""></span>mm/mo) were correlated with increased tissue invasion.</p><p id="par0030" class="elsevierStylePara elsevierViewall">In 1985, Fitzpatrick and Harwood reported on a series of fast-growing cSCCs they called <span class="elsevierStyleItalic">acute epitheliomas</span> that were associated with worse 3-year survival rates compared with cSCCs that did not exhibit rapid growth. The definition of rapid growth, however, was purely subjective, with no mention made of measurements.</p><p id="par0035" class="elsevierStylePara elsevierViewall">In 2002, Grob et al.<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">9</span></a> created an objective measure of melanoma growth, the melanoma kinetics index (MKI), which they expressed as follows:<elsevierMultimedia ident="eq0010"></elsevierMultimedia>where <span class="elsevierStyleItalic">t</span><span class="elsevierStyleInf">1</span> was the date on which the patient or family member first noticed the visible growth of the tumor and <span class="elsevierStyleItalic">t</span><span class="elsevierStyleInf">R</span> the date of resection. Growth was measured in millimeters per month. The authors used Breslow thickness as an indirect measure of tumor volume, which is more difficult to calculate. They observed a proportional relationship between disease-free survival rates and different quartiles of the MKI. While they acknowledged that patient-reported times are “subjective”, they added that “subjective does not mean inaccurate or irrelevant”.<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">9</span></a> Many authors are proponents of narrative-based medicine, which in contrast to evidence-based medicine, focuses on information that can be extracted from what patients tell their doctors during clinical interviews.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">10</span></a> Lin et al.,<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">11</span></a> on analyzing sequential biopsy specimens from the same melanomas, confirmed that growth rates calculated using information from clinical histories were a reliable clinical marker.</p><p id="par0040" class="elsevierStylePara elsevierViewall">Liu et al.,<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">12</span></a> in a 2006 Australian study investigating growth kinetics in melanoma, established that a third of melanomas could be considered fast-growing, which they defined as a growth rate of more than 0.5<span class="elsevierStyleHsp" style=""></span>mm/mo. Fast-growing melanomas were thicker, had a higher mitotic rate, and occurred more frequently in symptomatic patients and patients older than 70 years. The same group subsequently identified correlations between melanoma growth rate and proliferation markers Ki-67 and phosphohistone H3.<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">13</span></a> This characterization of fast-growing melanomas was corroborated by Martorell-Calatayud et al.,<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">14</span></a> who, on observing fewer associations with a history of sunburn, suggested the occurrence of another pathogenic pathway.</p><p id="par0045" class="elsevierStylePara elsevierViewall">In 2010, Tejera-Vaquerizo et al.,<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">15</span></a> followed by Nagore et al.,<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">16</span></a> showed that growth rate was an independent prognostic factor in melanoma. Growth rate has also been directly linked to a greater likelihood of sentinel node positivity in this setting.<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">17</span></a></p><p id="par0050" class="elsevierStylePara elsevierViewall">A correlation has also been found between melanoma growth rate and metastasis occurrence, with faster-growing tumors metastasizing earlier.<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">18</span></a> One study identified a critical time of metastasis occurrence after which fatal events may be seen and, paradoxically, faster-growing melanomas begin to metastasize at a greater thickness than thin melanomas.<a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">19</span></a></p><p id="par0055" class="elsevierStylePara elsevierViewall">Although <span class="elsevierStyleItalic">BRAF</span> mutations induce cell proliferation through interference with the MAP kinase pathway, they are not necessarily associated with faster-growing melanomas, although they are linked to higher mortality.<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">20</span></a> Co-occurrence of <span class="elsevierStyleItalic">BRAF</span> and <span class="elsevierStyleItalic">TERT</span> promoter mutations, has, by contrast, been associated with fast-growing melanomas,<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">21</span></a> which, more recently, have also been linked to fibroblast growth factor receptor 2 mutations, a potential marker of rapid growth.<a class="elsevierStyleCrossRef" href="#bib0250"><span class="elsevierStyleSup">22</span></a></p><p id="par0060" class="elsevierStylePara elsevierViewall">Evidence on growth rates in nonmelanoma skin tumors is more limited. In the case of cSCC, Cañueto et al.<a class="elsevierStyleCrossRef" href="#bib0255"><span class="elsevierStyleSup">23</span></a> calculated growth rate as the ratio between tumor diameter in mm and progression time. Using partition regression techniques, they determined that a rate of 4<span class="elsevierStyleHsp" style=""></span>mm/mo was the optimal cutoff for identifying fast-growing cSCCs. They also found that this cutoff was associated with a greater tendency for and earlier occurrence of regional lymphatic recurrences. Similarly to with other tumors, growth rate calculations for cSCCs are limited by subjective factors. Nonetheless, while BCCs grow consistently over time, this is less evident in the case of cSCCs,<a class="elsevierStyleCrossRef" href="#bib0260"><span class="elsevierStyleSup">24</span></a> whose size appears to depend more on growth rate than on time untreated. Time bias is lower in fast-growing tumors. In other words, these tumors tend to be diagnosed sooner because they are noticed earlier. In addition, growth from diagnosis to definitive treatment is easily measurable and could be useful for reliable calculations. The inclusion of depth measurements obtained by imaging techniques such as ultrasound could enable the calculation of tumor volume and add another element of precision to growth assessments.</p><p id="par0065" class="elsevierStylePara elsevierViewall">Analyses of BCC growth rates include the early study by Teloh<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">8</span></a> mentioned above and a descriptive study by Betti et al.,<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">25</span></a> who used both depth (Breslow thickness) and lateral extensions of excised tumors to assess rate of growth. The authors suggested that depth was a more useful measure for nodular subtypes, while lateral extension was more useful for superficial subtypes. In a study conducted in New Zealand, Sykes et al.<a class="elsevierStyleCrossRef" href="#bib0270"><span class="elsevierStyleSup">26</span></a> investigated the growth rate of BCCs using axial and longitudinal measurements and area growth rates in mm<span class="elsevierStyleSup">2</span>/mo, and confirmed that BCC is a slow-growing tumor and that prognosis is not significantly affected by diagnostic delays.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Tumor Doubling Time As A More Suitablemeasure</span><p id="par0070" class="elsevierStylePara elsevierViewall">The evidence to date on the kinetics of cutaneous tumors is based on growth rates measured in millimeters per month. As explained, calculations are based on tumor thickness or diameter as a surrogate for the more desirable measurement of tumor volume.</p><p id="par0075" class="elsevierStylePara elsevierViewall">Diameter could also be used to estimate tumor growth based on an exponential growth model designed by Tejera-Vaquerizo et al.<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">27</span></a> to estimate the effects of diagnostic delays due to the COVID-19 lockdown on SCC and melanoma growth. In the model, the dependent variable (<span class="elsevierStyleItalic">y</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>lesion size) and independent variable (<span class="elsevierStyleItalic">x</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>time) are linked as follows:<elsevierMultimedia ident="eq0015"></elsevierMultimedia><elsevierMultimedia ident="eq0020"></elsevierMultimedia></p><p id="par0080" class="elsevierStylePara elsevierViewall">Both <span class="elsevierStyleItalic">a</span> and <span class="elsevierStyleItalic">b</span> are adjustable, with <span class="elsevierStyleItalic">a</span> representing the initial size of the tumor and <span class="elsevierStyleItalic">b</span> its growth (the higher <span class="elsevierStyleItalic">b</span> is, the faster the tumor will grow). To estimate exponential tumor growth, it is necessary to know <span class="elsevierStyleItalic">y</span> (size) and <span class="elsevierStyleItalic">x</span> (time) at 2 distinct moments. In the equation, <span class="elsevierStyleItalic">y</span><span class="elsevierStyleInf">1</span> is the size of the tumor when it was first noticed by the patient or a family member and <span class="elsevierStyleItalic">y</span><span class="elsevierStyleInf">2</span> is its size at the time of surgery. Likewise, <span class="elsevierStyleItalic">x</span><span class="elsevierStyleInf">1</span> and <span class="elsevierStyleItalic">x</span><span class="elsevierStyleInf">2</span> indicate, respectively, when the tumor was first noticed and when it was excised.</p><p id="par0085" class="elsevierStylePara elsevierViewall">This equation can be used to calculate tumor growth when diameter size is known at 2 moments in time. Tumor doubling time, however, would be a more reliable indicator of kinetics.</p><p id="par0090" class="elsevierStylePara elsevierViewall">Schwartz,<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">2</span></a> in an evaluation of a potential exponential tumor growth model, used tumor volume measurements taken at 2 moments in time, thus calculating tumor volume doubling time (TVDT) as follows:<elsevierMultimedia ident="eq0025"></elsevierMultimedia>where <span class="elsevierStyleItalic">T</span> is the time and <span class="elsevierStyleItalic">V</span> is the volume at 2 different moments.</p><p id="par0095" class="elsevierStylePara elsevierViewall">It would be simpler, however, and probably more practical in the case of skin tumors, to calculate tumor diameter doubling time (TDDT), which would be as follows<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">2</span></a>:<elsevierMultimedia ident="eq0030"></elsevierMultimedia>where <span class="elsevierStyleItalic">T</span> is the time and <span class="elsevierStyleItalic">D</span> is the diameter at 2 different moments.</p><p id="par0100" class="elsevierStylePara elsevierViewall">We present 2 examples of this calculation applied to SCCs on the scalp:<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><p id="par0105" class="elsevierStylePara elsevierViewall">Example 1 (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>A and B) involves an SCC located on the scalp with a diameter of 27<span class="elsevierStyleHsp" style=""></span>mm at <span class="elsevierStyleItalic">T</span><span class="elsevierStyleInf">1</span> (<span class="elsevierStyleItalic">D</span><span class="elsevierStyleInf">1</span>) and 53<span class="elsevierStyleHsp" style=""></span>mm at <span class="elsevierStyleItalic">T</span><span class="elsevierStyleInf">2</span> (<span class="elsevierStyleItalic">D</span><span class="elsevierStyleInf">2</span>) and a time from <span class="elsevierStyleItalic">T</span><span class="elsevierStyleInf">1</span> to <span class="elsevierStyleItalic">T</span><span class="elsevierStyleInf">2</span> (<span class="elsevierStyleItalic">T</span><span class="elsevierStyleInf">2</span><span class="elsevierStyleHsp" style=""></span>−<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">T</span><span class="elsevierStyleInf">1</span>) of 84 days. The corresponding TDDT would be 7.3 days.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia></li><li class="elsevierStyleListItem" id="lsti0010"><p id="par0110" class="elsevierStylePara elsevierViewall">Example 2 (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>C and D) involves another SCC located on the scalp with a <span class="elsevierStyleItalic">D</span><span class="elsevierStyleInf">1</span> of 20<span class="elsevierStyleHsp" style=""></span>mm, a <span class="elsevierStyleItalic">D</span><span class="elsevierStyleInf">2</span> of 28<span class="elsevierStyleHsp" style=""></span>mm, and a <span class="elsevierStyleItalic">T</span><span class="elsevierStyleInf">2</span><span class="elsevierStyleHsp" style=""></span>−<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">T</span><span class="elsevierStyleInf">1</span> of 133 days. In this case, the TDDT would be 16.1 days.</p></li></ul></p><p id="par0115" class="elsevierStylePara elsevierViewall">A shorter TDDT in lesions with a similar initial size would ultimately indicate a higher-risk CSS, even with a shorter time to diagnosis.</p><p id="par0120" class="elsevierStylePara elsevierViewall">TDDT, however, is not practical in routine clinical practice, as in the vast majority of cases, the only known diameter is that measured at the time of the visit.</p><p id="par0125" class="elsevierStylePara elsevierViewall">To overcome this limitation, we propose using a visual scale consisting of circles ranging from 1<span class="elsevierStyleHsp" style=""></span>mm to 29<span class="elsevierStyleHsp" style=""></span>mm (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>) (Supplementary Table 1) to estimate <span class="elsevierStyleItalic">D</span><span class="elsevierStyleInf">1</span>. Just as a patient can more or less recall when they first noticed a lesion, they may also recall its approximate size. We believe that this estimate is subject to the same uncertainty as that described for time of onset.</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0130" class="elsevierStylePara elsevierViewall">We are currently investigating the potential applicability of estimated TDDT (eTDDT) in the field of skin cancer. During the COVID-19 pandemic, we conducted a multicenter study on the impact of lockdown on melanoma and cSCC size and thickness in Spain.<a class="elsevierStyleCrossRef" href="#bib0280"><span class="elsevierStyleSup">28</span></a> The researchers were asked to show patients the visual scale in <a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a> at the first visit to estimate the size of the tumor when they had first noticed it. More than 90% of patients provided an estimate (unpublished data). In the coming months we will have sufficient data to attempt to characterize and link eTDDT to different clinical and pathologic features of the tumors analyzed.</p><p id="par0135" class="elsevierStylePara elsevierViewall">Just as Liu et al.<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">12</span></a> in their characterization of tumor growth rate determined that up to a third of melanomas were fast growing, it might be possible to apply eTDDT percentiles to determine, the proportions of SCCs, melanomas, and other types of skin cancer that are fast or slow growing. Such estimates could inform both treatment and follow-up decisions.</p><p id="par0140" class="elsevierStylePara elsevierViewall">In our opinion, eTDDT is a simple, novel tool that is worth analyzing.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Conflicts Of Interest</span><p id="par0145" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:9 [ 0 => array:3 [ "identificador" => "xres1857877" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1615304" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres1857878" "titulo" => "Resumen" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0010" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec1615305" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Skin Tumor Growth Rate" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Tumor Doubling Time As A More Suitablemeasure" ] 7 => array:2 [ "identificador" => "sec0020" "titulo" => "Conflicts Of Interest" ] 8 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2022-06-16" "fechaAceptado" => "2022-10-09" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1615304" "palabras" => array:4 [ 0 => "Melanoma" 1 => "Cutaneous squamous cell carcinoma" 2 => "Kinetics" 3 => "Theoretical models" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec1615305" "palabras" => array:4 [ 0 => "Melanoma" 1 => "Carcinoma cutáneo de células escamosas" 2 => "Cinética" 3 => "Modelos teóricos" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Skin cancer, like other cancers, is characterized by the uncontrolled growth of transformed cells. Tumor growth has been studied for decades. We review different methods for measuring skin tumor growth and propose a new system for estimating tumor doubling time that could be useful in the management of skin cancer.</p></span>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">El cáncer de piel al igual que otros tumores internos está compuesto por células transformadas de crecimiento incontrolado. El crecimiento tumoral ha sido objeto de estudio desde hace décadas. En este artículo se repasan las distintas formas de medición del crecimiento tumoral cutáneo y se establecen las bases para el desarrollo de una estimación del tiempo de duplicación tumoral que pueda ser útil en el manejo de los pacientes con cáncer de piel.</p></span>" ] ] "multimedia" => array:8 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2263 "Ancho" => 2009 "Tamanyo" => 386787 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Squamous cell carcinoma on the scalp with a diameter of 27<span class="elsevierStyleHsp" style=""></span>mm at time 1 (<span class="elsevierStyleItalic">T</span><span class="elsevierStyleInf">1</span>) (A) and 53<span class="elsevierStyleHsp" style=""></span>mm at <span class="elsevierStyleItalic">T</span><span class="elsevierStyleInf">2</span>, 84 days later (B). Squamous cell carcinoma on the scalp with a diameter of 20<span class="elsevierStyleHsp" style=""></span>mm at <span class="elsevierStyleItalic">T</span><span class="elsevierStyleInf">1</span> (C) and 28<span class="elsevierStyleHsp" style=""></span>mm at 133 days (<span class="elsevierStyleItalic">T</span><span class="elsevierStyleInf">2</span>) (D).</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1440 "Ancho" => 2927 "Tamanyo" => 99506 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Proposed visual scale for estimating tumor size as recalled by the patient.</p>" ] ] 2 => array:6 [ "identificador" => "eq0005" "etiqueta" => "(1)" "tipo" => "MULTIMEDIAFORMULA" "mostrarFloat" => false "mostrarDisplay" => true "Formula" => array:5 [ "Matematica" => "Growth rate=tumor size in mmduration of the tumor in months" "Fichero" => "STRIPIN_si1.jpeg" "Tamanyo" => 3831 "Alto" => 31 "Ancho" => 313 ] ] 3 => array:6 [ "identificador" => "eq0010" "etiqueta" => "(2)" "tipo" => "MULTIMEDIAFORMULA" "mostrarFloat" => false "mostrarDisplay" => true "Formula" => array:5 [ "Matematica" => "MKI=Tumor thicknesst1−tR" "Fichero" => "STRIPIN_si2.jpeg" "Tamanyo" => 1989 "Alto" => 34 "Ancho" => 151 ] ] 4 => array:6 [ "identificador" => "eq0015" "etiqueta" => "(3)" "tipo" => "MULTIMEDIAFORMULA" "mostrarFloat" => false "mostrarDisplay" => true "Formula" => array:5 [ "Matematica" => "y=a⋅ebx" "Fichero" => "STRIPIN_si3.jpeg" "Tamanyo" => 642 "Alto" => 17 "Ancho" => 67 ] ] 5 => array:6 [ "identificador" => "eq0020" "etiqueta" => "(4)" "tipo" => "MULTIMEDIAFORMULA" "mostrarFloat" => false "mostrarDisplay" => true "Formula" => array:5 [ "Matematica" => "b=In(y2/y1)x2−x1" "Fichero" => "STRIPIN_si4.jpeg" "Tamanyo" => 1253 "Alto" => 33 "Ancho" => 89 ] ] 6 => array:6 [ "identificador" => "eq0025" "etiqueta" => "(5)" "tipo" => "MULTIMEDIAFORMULA" "mostrarFloat" => false "mostrarDisplay" => true "Formula" => array:5 [ "Matematica" => "TVDT=log 2(T2−T1)log(V2/V1)" "Fichero" => "STRIPIN_si5.jpeg" "Tamanyo" => 2153 "Alto" => 35 "Ancho" => 145 ] ] 7 => array:6 [ "identificador" => "eq0030" "etiqueta" => "(6)" "tipo" => "MULTIMEDIAFORMULA" "mostrarFloat" => false "mostrarDisplay" => true "Formula" => array:5 [ "Matematica" => "TDDT=log 2(T2−T1)3  log (D2/D1)" "Fichero" => "STRIPIN_si6.jpeg" "Tamanyo" => 2306 "Alto" => 35 "Ancho" => 145 ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:28 [ 0 => array:3 [ "identificador" => "bib0145" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Observations on growth rates of human tumors" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "V.P. Collins" 1 => "R.K. Loeffler" 2 => "H. Tivey" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Roentgenol Radium Ther Nucl Med" "fecha" => "1956" "volumen" => "76" "paginaInicial" => "988" "paginaFinal" => "1000" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/13362715" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0150" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A biomathematical approach to clinical tumor growth" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M. Schwartz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/1097-0142(196111/12)14:6<1272::AID-CNCR2820140618>3.0.CO;2-H" "Revista" => array:6 [ "tituloSerie" => "Cancer" "fecha" => "1961" "volumen" => "14" "paginaInicial" => "1272" "paginaFinal" => "1294" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/13909709" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0155" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Estimating tumor growth rates in vivo" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Talkington" 1 => "R. Durrett" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11538-015-0110-8" "Revista" => array:5 [ "tituloSerie" => "Bull Math Biol" "fecha" => "2015" "volumen" => "77" "paginaInicial" => "1934" "paginaFinal" => "1954" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0160" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "On the growth rates of human malignant tumors: implications for medical decision making" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S. Friberg" 1 => "S. Mattson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.3.CO;2-N" "Revista" => array:6 [ "tituloSerie" => "J Surg Oncol" "fecha" => "1997" "volumen" => "65" "paginaInicial" => "284" "paginaFinal" => "297" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9274795" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0165" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rates of growth of human solid neoplasms: Part I" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J.S. Spratt" 1 => "J.S. Meyer" 2 => "J.A. Spratt" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jso.2930600216" "Revista" => array:6 [ "tituloSerie" => "J Surg Oncol" "fecha" => "1995" "volumen" => "60" "paginaInicial" => "137" "paginaFinal" => "146" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7564383" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0170" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rates of growth of human neoplasms: Part II" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J.S. Spratt" 1 => "J.S. Meyer" 2 => "J.A. Spratt" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/1096-9098(199601)61:1<68::AID-JSO2930610102>3.0.CO;2-E" "Revista" => array:6 [ "tituloSerie" => "J Surg Oncol" "fecha" => "1996" "volumen" => "61" "paginaInicial" => "68" "paginaFinal" => "83" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8544465" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0175" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "NCCN Guidelines Version 2.2022 Squamous Cell Skin Cancer Continue NCCN Guidelines" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "N. Mai Nguyen" 1 => "B. McCullough" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:1 [ "fecha" => "2022" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0180" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Correlation rate of growth with histologic characteristics of basal cell carcinoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "H.A. Teloh" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "AMA Arch Derm Syphilol" "fecha" => "1953" "volumen" => "68" "paginaInicial" => "408" "paginaFinal" => "416" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0185" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The kinetics of the visible growth of a primary melanoma reflects the tumor aggressiveness and is an independent prognostic marker: a prospective study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.J. Grob" 1 => "M.A. Richard" 2 => "J. Gouvernet" 3 => "M.F. Avril" 4 => "M. Delaunay" 5 => "P. Wolkenstein" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ijc.10660" "Revista" => array:6 [ "tituloSerie" => "Int J Cancer" "fecha" => "2002" "volumen" => "102" "paginaInicial" => "34" "paginaFinal" => "38" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12353231" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0190" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Narrative based medicine: narrative based medicine in an evidence based world" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "T. Greenhalgh" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bmj.318.7179.323" "Revista" => array:6 [ "tituloSerie" => "BMJ" "fecha" => "1999" "volumen" => "318" "paginaInicial" => "323" "paginaFinal" => "325" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9924065" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0195" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An objective measure of growth rate using partial biopsy specimens of melanomas that were initially misdiagnosed" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M.J. Lin" 1 => "V. Mar" 2 => "C. McLean" 3 => "J.W. Kelly" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2014.04.068" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2014" "volumen" => "71" "paginaInicial" => "691" "paginaFinal" => "697" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24976443" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0200" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "W. Liu" 1 => "J.P. Dowling" 2 => "W.K. Murray" 3 => "G.A. McArthur" 4 => "J.F. Thompson" 5 => "R. Wolfe" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archderm.142.12.1551" "Revista" => array:6 [ "tituloSerie" => "Arch Dermatol" "fecha" => "2006" "volumen" => "142" "paginaInicial" => "1551" "paginaFinal" => "1558" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17178980" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0205" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Correlation of subjective self-reported melanoma growth rate with objective tumor proliferation markers" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "W. Liu" 1 => "G.A. McArthur" 2 => "M. Trivett" 3 => "W.K. Murray" 4 => "R. Wolfe" 5 => "J.W. Kelly" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archderm.144.4.555" "Revista" => array:3 [ "tituloSerie" => "Arch Dermatol" "fecha" => "2008" "volumen" => "144" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0210" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Defining fast-growing melanomas" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Martorell-Calatayud" 1 => "E. Nagore" 2 => "R. Botella-Estrada" 3 => "D. Scherer" 4 => "C. Requena" 5 => "C. Serra-Guillén" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/CMR.0b013e328342f312" "Revista" => array:6 [ "tituloSerie" => "Melanoma Res" "fecha" => "2011" "volumen" => "21" "paginaInicial" => "131" "paginaFinal" => "138" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21183860" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0215" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Growth rate as a prognostic factor in localized invasive cutaneous melanoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A. Tejera-Vaquerizo" 1 => "M.V. Barrera-Vigo" 2 => "N. López-Navarro" 3 => "E. Herrera-Ceballos" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1468-3083.2009.03367.x" "Revista" => array:6 [ "tituloSerie" => "J Eur Acad Dermatol Venereol" "fecha" => "2010" "volumen" => "24" "paginaInicial" => "147" "paginaFinal" => "154" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19627405" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0220" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Growth rate as an independent prognostic factor in localized invasive cutaneous melanoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "E. Nagore" 1 => "A. Martorell-Calatayud" 2 => "R. Botella-Estrada" 3 => "C. Guillén" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1468-3083.2011.04029.x" "Revista" => array:6 [ "tituloSerie" => "J Eur Acad Dermatol Venereol" "fecha" => "2011" "volumen" => "25" "paginaInicial" => "618" "paginaFinal" => "620" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21492248" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0225" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prediction of sentinel lymph node positivity by growth rate of cutaneous melanoma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Tejera-Vaquerizo" 1 => "E. Nagore" 2 => "E. Herrera-Acosta" 3 => "A. Martorell-Calatayud" 4 => "P. Martín-Cuevas" 5 => "V. Traves" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archdermatol.2011.2522" "Revista" => array:5 [ "tituloSerie" => "Arch Dermatol" "fecha" => "2012" "volumen" => "148" "paginaInicial" => "1" "paginaFinal" => "8" ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0230" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Correlation of the growth rate of melanoma with the temporal appearance of metastasis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A. Tejera-Vaquerizo" 1 => "N. Lopez-Navarro" 2 => "A. Alcaide-Martin" 3 => "E. Herrera-Acosta" 4 => "E. Herrera-Ceballos" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1468-3083.2010.03723.x" "Revista" => array:6 [ "tituloSerie" => "J Eur Acad Dermatol Venereol" "fecha" => "2011" "volumen" => "25" "paginaInicial" => "366" "paginaFinal" => "367" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20524941" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0235" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Chronology of metastasis in cutaneous melanoma: growth rate model" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Tejera-Vaquerizo" 1 => "E. Nagore" 2 => "J.J. Meléndez" 3 => "N. López-Navarro" 4 => "A. Martorell-Calatayud" 5 => "E. Herrera-Acosta" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/jid.2011.433" "Revista" => array:5 [ "tituloSerie" => "J Invest Dermatol" "fecha" => "2012" "volumen" => "132" "paginaInicial" => "1215" "paginaFinal" => "1221" ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0240" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of BRAF mutations in primary melanoma growth rate and survival" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "V.J. Mar" 1 => "W. Liu" 2 => "B. Devitt" 3 => "S.Q. Wong" 4 => "A. Dobrovic" 5 => "G.A. McArthur" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/bjd.13756" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2015" "volumen" => "173" "paginaInicial" => "76" "paginaFinal" => "82" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25752325" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0245" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "TERT promoter mutations associate with fast-growing melanoma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E. Nagore" 1 => "B. Heidenreich" 2 => "C. Requena" 3 => "Z. García-Casado" 4 => "A. Martorell-Calatayud" 5 => "V. Pont-Sanjuan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/pcmr.12441" "Revista" => array:6 [ "tituloSerie" => "Pigment Cell Melanoma Res" "fecha" => "2016" "volumen" => "29" "paginaInicial" => "236" "paginaFinal" => "238" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26575949" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0250" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Molecular characterization of fast-growing melanomas" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Gaudy-Marqueste" 1 => "N. Macagno" 2 => "A. Loundou" 3 => "E. Pellegrino" 4 => "L. Ouafik" 5 => "T. Budden" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2021.07.011" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2022" "volumen" => "86" "paginaInicial" => "312" "paginaFinal" => "321" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34280484" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0255" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rapid growth rate is associated with poor prognosis in cutaneous squamous cell carcinoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "J. Cañueto" 1 => "J. Martín-Vallejo" 2 => "E. Cardeñoso-Álvarez" 3 => "E. Fernández-López" 4 => "J. Pérez-Losada" 5 => "C. Román-Curto" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ced.13570" "Revista" => array:6 [ "tituloSerie" => "Clin Exp Dermatol" "fecha" => "2018" "volumen" => "43" "paginaInicial" => "876" "paginaFinal" => "882" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29756221" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0260" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Basal cell carcinoma and squamous cell carcinoma growth rates and determinants of size in community patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Kricker" 1 => "B. Armstrong" 2 => "V. Hansen" 3 => "A. Watson" 4 => "G. Singh-Khaira" 5 => "C. Lecathelinais" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2013.11.009" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2014" "volumen" => "70" "paginaInicial" => "456" "paginaFinal" => "464" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24373780" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0265" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Growth rate of different basal cell carcinoma subtypes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "R. Betti" 1 => "L. Moneghini" 2 => "E.T. Mapelli" 3 => "G. Bulfamante" 4 => "A. Cerri" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1684/ejd.2017.3073" "Revista" => array:5 [ "tituloSerie" => "Eur J Dermatol" "fecha" => "2017" "volumen" => "27" "paginaInicial" => "544" "paginaFinal" => "545" ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0270" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Growth rate of clinically diagnosed superficial basal cell carcinoma and changes in dermoscopic features over time" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A.J. Sykes" 1 => "C. Wlodek" 2 => "A. Trickey" 3 => "G.L. Clayton" 4 => "A. Oakley" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ajd.13352" "Revista" => array:6 [ "tituloSerie" => "Australas J Dermatol" "fecha" => "2020" "volumen" => "61" "paginaInicial" => "330" "paginaFinal" => "336" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32578200" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0275" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Estimación del efecto en el tamaño y la supervivencia de los tumores cutáneos debido al confinamiento por COVID-19: modelo basado en un crecimiento exponencial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Tejera-Vaquerizo" 1 => "J. Cañueto" 2 => "A. Toll" 3 => "J. Santos-Juanes" 4 => "A. Jaka" 5 => "C. Ferrandiz-Pulido" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ad.2020.05.001" "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2020" "volumen" => "111" "paginaInicial" => "629" "paginaFinal" => "638" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32513393" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0280" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of covid-19 lockdown on tumour burden of melanoma and cutaneous squamous cell carcinoma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Tejera-Vaquerizo" 1 => "S. Paradela" 2 => "A. Toll" 3 => "J. Santos-Juanes" 4 => "A. Jaka" 5 => "A. López" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Acta Derm Venereol" "fecha" => "2021" "volumen" => "101" "paginaInicial" => "adv00525" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/00017310/0000011400000003/v1_202303051528/S0001731023000716/v1_202303051528/en/main.assets" "Apartado" => array:4 [ "identificador" => "6180" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Dermatología práctica" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/00017310/0000011400000003/v1_202303051528/S0001731023000716/v1_202303051528/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731023000716?idApp=UINPBA000044" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 21 | 15 | 36 |
2024 October | 155 | 75 | 230 |
2024 September | 196 | 54 | 250 |
2024 August | 183 | 75 | 258 |
2024 July | 117 | 59 | 176 |
2024 June | 140 | 66 | 206 |
2024 May | 156 | 65 | 221 |
2024 April | 118 | 36 | 154 |
2024 March | 108 | 48 | 156 |
2024 February | 130 | 34 | 164 |
2024 January | 126 | 28 | 154 |
2023 December | 240 | 21 | 261 |
2023 November | 320 | 31 | 351 |
2023 October | 424 | 40 | 464 |
2023 September | 306 | 27 | 333 |
2023 August | 290 | 24 | 314 |
2023 July | 342 | 41 | 383 |
2023 June | 154 | 24 | 178 |
2023 May | 147 | 35 | 182 |
2023 April | 122 | 35 | 157 |
2023 March | 205 | 60 | 265 |
2023 February | 63 | 56 | 119 |